Gels (May 2024)

Fluoride-Ion-Responsive Sol–Gel Transition in an L-Cysteine/AgNO<sub>3</sub> System: Self-Assembly Peculiarities and Anticancer Activity

  • Dmitry V. Vishnevetskii,
  • Yana V. Andrianova,
  • Elizaveta E. Polyakova,
  • Alexandra I. Ivanova,
  • Arif R. Mekhtiev

DOI
https://doi.org/10.3390/gels10050332
Journal volume & issue
Vol. 10, no. 5
p. 332

Abstract

Read online

Supramolecular hydrogels based on low-molecular-weight compounds are a unique class of so-called “soft” materials, formed by weak non-covalent interactions between precursors at their millimolar concentrations. Due to the variety of structures that can be formed using different low-molecular-weight gelators, they are widely used in various fields of technology and medicine. In this study, we report for the first time an unusual self-assembly process of mixing a hydrosol obtained from L-cysteine and silver nitrate (cysteine–silver sol—CSS) with sodium halides. Modern instrumental techniques such as viscosimetry, UV spectroscopy, dynamic light scattering, zeta potential measurements, SEM and EDS identified that adding fluoride anions to CSS is able to form stable hydrogels of a thixotropic nature, while Cl−, Br− and I− lead to precipitation. The self-assembly process proceeds using a narrow concentration range of F−. An increase in the fluoride anion content in the system leads to a change in the gel network morphology from elongated structures to spherical ones. This fact is reflected in a decrease in the gel viscosity and a number of gel–sol–gel transition cycles. The mechanism of F−’s interaction with hydrosol includes the condensation of anions on the positive surface of the CSS nanoparticles, their binding via electrostatic forces and the formation of a resulting gel carcass. In vitro analysis showed that the hydrogels suppressed human squamous carcinoma cells at a micromolar sample concentration. The obtained soft gels could have potential applications against cutaneous malignancy and as carriers for fluoride anion and other bioactive substance delivery.

Keywords